Maria Carla Dominguez, MD

Srikanth Nagalla, M.D., is chief of benign hematology at Miami Cancer Institute. Dr. Nagalla specializes in treating benign (non-cancerous) hematological conditions, including bleeding and clotting disorders, rare blood disorders, high and low platelets, high and low blood counts, bone marrow failure syndromes and myeloproliferative neoplasms. In addition to his extensive experience in benign hematology, Dr. Nagalla has a master’s degree in microbiology and immunology. He has also contributed significant research to the field of platelet biology that could have a lasting impact on how diseases are treated in the future. He has authored numerous peer-reviewed journal articles and book chapters in the field of hematology. Dr. Nagalla joined Miami Cancer Institute from UT Southwestern Medical Center in Dallas, Texas. Throughout his career, he has served in multiple leadership roles. Dr. Nagalla has a strong understanding of the pathophysiology of blood disorders, which is important when developing personalized treatment plans. It allows him to think outside of the box and provide treatment options that are most beneficial to his patients. He believes in educating patients and their caregivers so they can serve as partners and advocates in the treatment process and experience better outcomes. Dr. Nagalla is also passionate about training the next generation of physicians. He has received several awards for his work in teaching medical students and trainees. He serves on multiple national committees for medical education.When he is not treating patients, Dr. Nagalla enjoys spending time with his family, traveling and golfing.

Romer Orada, D.O., is a physical medicine and rehabilitation physician at Miami Cancer Institute. Dr. Orada specializes in cancer rehabilitation and treats patients who have impairments related to cancer or associated treatments. These include musculoskeletal disorders, neuropathy, weakness, gait difficulty, balance problems, spasticity, contracture, difficulty swallowing and lymphedema. He is fluent in English and Filipino/Tagalog. He works with a multidisciplinary team and uses treatments like non-opioid medications, targeted therapy/exercise prescriptions, therapeutic injections, bracing/orthotics, assistive devices and education to provide a comprehensive treatment plan for his patients with cancer-related impairments or disabilities.Dr. Orada joined Miami Cancer Institute from the University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, where he served as an assistant professor in the Department of Physical Medicine and Rehabilitation. During his cancer rehabilitation fellowship at Memorial Sloan Kettering Cancer Center in New York City, Dr. Orada served as a co-investigator for a case series of breast lymphedema. He is also a frequent speaker and lecturer on topics related to cancer rehabilitation. During his residency, Dr. Orada was named chief resident and resident of the year. He also served as the residency rotation director of the Cancer Rehabilitation PM&R rotation at the University of Pittsburgh Medical Center. Dr. Orada takes a holistic approach to caring for his patients. He considers their diagnosis and how the disease process affects a person’s overall well-being physically, emotionally, mentally, socially and spiritually. His goal is to optimize function, prevent further impairment and improve the quality of life for people undergoing cancer treatment, no matter where they are in the cancer journey. When he is not treating patients, Dr. Orada enjoys tennis, watching college basketball, trying new restaurants, anything outdoors, and traveling with his wife and family.

Rupesh Kotecha, M.D., is a radiation oncologist at Miami Cancer Institute. Dr. Kotecha has specialized training and experience in utilizing the latest in radiation therapy treatment techniques to treat cancer and noncancerous conditions. His research background and clinical interests have primarily focused on the treatment of patients with stereotactic radiosurgery and stereotactic body radiation therapy. He has a specific interest and expertise in the use of stereotactic radiosurgery in the management of brain metastases to help improve both patient outcomes and quality of life.